GLX, created in 2012 (United States), from 150 sister brands and 2279 competing brands. GLX is owned by Edwards Lifesciences, listed on the stock exchange of New York The sector of GLX is Medical Devices & Instruments.
Investment simulator :
Portfolio valuation
Edwards Lifesciences
(GLX)
over 5 years*
USD 125.26